Form CORRESP - Correspondence:
SEC Accession No. 0001193125-20-236337
Filing Date
2020-08-31
Accepted
2020-08-31 17:00:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 7083
  Complete submission text file 0001193125-20-236337.txt   8151
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations